Federal Law Applies In Cordis Stent Case: NJ Court

Law360, New York (July 27, 2010, 6:26 PM EDT) -- A New Jersey appeals court has ruled that some product liability claims involving an allegedly defective coronary stent made by medical manufacturer Cordis Corp. are preempted by the Medical Device Amendments of 1976 to the Food, Drug and Cosmetic Act, while others remain in the hands of the state.

The Superior Court of New Jersey, Appellate Division, on Friday affirmed a decision by the court’s Law Division that federal law preempts certain claims of strict product liability, breach of express and implied warranty, and derivative claims...
To view the full article, register now.